Ingevity CORP Form 4 insider transactions

David H Li, President & CEO and a Director of Ingevity Corp, sold 10,000 shares of common stock on August 12, 2026.

Phillip John Platt, SVP, Chief Financial Officer of Ingevity Corp, reported a transaction in 1,698 shares of common stock on August 10, 2026.

Ryan C. Fisher, SVP, Gen. Counsel & Secretary of Ingevity Corp, sold 2,709 shares of common stock on August 3, 2026.

Phillip John Platt, SVP, Chief Financial Officer of Ingevity Corp, reported a transaction in 3,294 shares of common stock on July 24, 2026.

Ingevity Corp's SVP, Gen. Counsel & Secretary, Ryan C. Fisher, reported transactions involving common stock, including shares withheld for taxes and shares purchased through an employee stock purchase plan.

Ingevity Corp. director J. Kevin Willis acquired 397 shares of common stock through a deferred compensation plan.

Ingevity Corp. director Francis David Segal acquired 328 shares of common stock through vested deferred stock units.

Ingevity Corp's VP, Chief Accounting Officer, Ryan Joseph Cotterman, was granted 2,063 restricted stock units under the company's 2025 Omnibus Incentive Plan.

Terrance M. Dyer, SVP and Chief HR Officer of Ingevity Corp, reported the sale of 526 shares of common stock on May 28, 2026.

Ingevity Corporation SVP of Finance and CAO Phillip J. Platt was granted 1,262 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Director Luis M. Fernandez-Moreno was granted 1,904 restricted stock units in Ingevity Corporation as part of the 2025 Omnibus Incentive Plan.

Ingevity Corporation director Diane H. Gulyas was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Ingevity Corporation director Bruce D. Hoechner was granted 1,904 deferred stock units in lieu of his annual restricted stock unit award.

Director Frederick J. Lynch acquired 1,904 restricted stock units in Ingevity Corporation as part of an equity incentive plan.

Ingevity Corporation director Karen G. Narwold was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Ingevity Corporation director Francis David Segal was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Director J. Kevin Willis acquired 1,904 deferred stock units in lieu of an annual restricted stock unit grant.

Director Benjamin G. Wright acquired 1,904 deferred stock units in lieu of his annual restricted stock unit grant.

Ingevity Corp. President & CEO David H. Li reported transactions involving the purchase and sale of company stock, acquiring 13,102 shares and disposing of 3,574 shares on April 7, 2026.

Director Francis David Segal acquired 329 shares of Ingevity Corp. common stock through vested deferred stock units.

Ingevity Corp. director J. Kevin Willis acquired 398 shares of common stock through vested deferred stock units.

Ingevity's SVP, General Counsel & Secretary, Ryan C. Fisher, reported a disposition of 308 common shares to cover tax withholdings from vested 2024 RSUs.

Ingevity's SVP of Operations, Clarence Reid Clontz Jr., reported the grant of 2,343 restricted stock units and subsequent sales to cover tax obligations from vested RSUs.

Ingevity's SVP of Finance and CAO, Phillip John Platt, reported the grant of 2,108 restricted stock units and subsequent sales of shares to cover tax obligations from vested RSUs.

Ingevity's SVP, General Counsel & Secretary, Ryan C. Fisher, received a grant of 4,442 restricted stock units and had shares withheld for tax obligations related to previously vested RSUs.

Ingevity Corp's SVP and President of Performance Chemicals, Richard Allen White Jr., disposed of shares to cover tax obligations from vested restricted stock units.

Ingevity's EVP and CFO, Mary Dean Hall, reported the disposition of shares to cover tax obligations related to vested restricted stock units.

Ingevity's SVP, Chief HR Officer, Terrance M. Dyer, received a grant of 3,621 restricted stock units and disposed of 550 shares for tax withholding.

Ingevity Corporation's SVP and President of APT, Michael N. Shukov, was granted 1,389 restricted stock units vesting over three years.

Ingevity Corporation's Senior Vice President and President of Performance Materials, Ruth Castillo, was granted 3,688 restricted stock units, aligning executive incentives with shareholder value.